Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA

Journal of Medical Microbiology

Volumn 55, Issue 11, 2006, Pages 1527-1531

  Guo, Hongling ^a   Seet, Qihui ^a   Denkin, Steven ^a   Parsons, Linda ^b   Zhang, Ying ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CATALASE; GENOMIC DNA; ISONIAZID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME ASSAY; GENE MUTATION; INHA GENE; KATG GENE; MABA GENE; MYCOBACTERIUM TUBERCULOSIS; NDH GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUBERCULOSIS; UNITED STATES;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TUBERCULOSIS; UNITED STATES;

EID: 33750828139     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46718-0     Document Type: Article

References (32)

1. Baker, L. V., Brown, T. J., Maxwell, O., Gibson, A. L., Fang, Z., Yates, M. D. & Drobniewski, F. A. (2005). Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob Agents Chemother 49, 1455-1464.
2. Bakonyte, D., Baranauskaite, A., Cicenaite, J., Sosnovskaja, A. & Stakenas, P. (2003). Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother 47, 2009-2011.
3. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G. & Jacobs, W. R., Jr (1994). inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230.
4. Baulard, A. R., Betts, J. C., Engohang-Ndong, J., Quan, S., McAdams, R. A., Brennan, P. J., Locht, C. & Besra, G. S. (2000). Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem 275, 28326-28331.
5. Broussy, S., Coppel, Y., Nguyen, M., Bernadou, J. & Meunier, B. (2003). 1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis. Chemistry 9, 2034-2038.
6. Cole, S. T., Brosch, R., Parkhill, J. & 39 other authors (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
7. DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L. G. & Barry, C. E., III (2000). Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 97, 9677-9682.
8. Heym, B., Alzarl, P. M., Honore, N. & Cole, S. T. (1995). Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 15, 235-245.
9. Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A. & Wong, S. Y. (1999). Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob Agents Chemother 43, 2087-2089.
10. Lee, A. S. G., Teo, A. S. M. & Wong, S.-Y. (2001). Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 45, 2157-2159.
11. Madison, B. M., Siddiqi, S. H., Heifets, L., Gross, W., Higgins, M., Warren, N., Thompson, A., Morlock, G. & Ridderhof, J. C. (2004). Identification of a Mycobacterium tuberculosis strain with stable, low-level resistance to isoniazid. J Clin Microbiol 42, 1294-1295.
12. Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M. & Barry, C. E. (1998). Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science 280, 1607-1610.
13. Middlebrook, G. (1954). Isoniazid resistance and catalase activity of tubercle bacilli: a preliminary report. Am Rev Tuberc 69, 471-472.
14. Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R. & Jacobs, W. R. Jr (1998). NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J Bacteriol 180, 2459-2467.
15. Morlock, G. P., Metchock, B., Sikes, D., Crawford, J. T. & Cooksey, R. C. (2003). ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 47, 3799-3805.
16. Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D. & van Embden, J. D. (1996). Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 173, 196-202.
17. Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T. & Graviss, E. A. (2003). Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 47, 1241-1250,
18. Raviglione, M. C. (2003). The TB epidemic from 1992 to 2002. Tuberculosis 83, 4-14.
19. Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., Jr & Sacchettini, J. C. (1998). Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279, 98-102.
20. Sajduda, A., Brzostek, A., Poplawska, M., Augustynowicz-Kopec, E., Zwolska, Z., Niemann, S., Dziadek, J. & Hillemann, D. (2004). Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol 42, 2425-2431.
21. Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., III & Stover, C. K. (1996). Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272, 1641-1643.
22. Shoeb, H. A., Bowman, B. U., Jr, Ottolenghi, A. C. & Merola, A. J. (1985). Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 27, 404-407.
23. Siddiqi, S. H. (1992). Antimicrobial susceptibility testing: radiometric (BACTEC) tests for slowly growing mycobacteria. In Clinical Microbiology Procedures Handbook, pp.14-25. Edited by H. D. Isenberg. Washington, DC: American Society for Microbiology.
24. Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E. & Cole, S. T. (1997). Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35, 719-723.
25. + ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother 49, 708-720.
26. Wengenack, N. L., Todorovic, S., Yu, L. & Rusnak, F. (1998). Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). Biochemistry 37, 15825-15834.
27. Wilson, T. M. & Collins, D. M. (1996). ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol Microbiol 19, 1025-1034.
28. Yu, S., Girotto, S., Lee, C. & Magliozzo, R. S. (2003). Reduced affinity for isoniazid in the S31ST mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. J Biol Chem 278, 14769-14775.
29. Zhang, Y. (2004). Isoniazid. In Tuberculosis, 2nd edn, pp. 739-758. Edited by W. N. Rom & S. M. Garay. New York: Lippincott Williams & Wilkins.
30. Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, S. (1992). The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591-593.
31. Zhang, Y., Garbe, T. & Young, D. (1993). Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol 8, 521-524.
32. Zhang, Y., Vilchèze, C. & Jacobs, W. R. (2005). Mechanisms of drug resistance in Mycobacterium tuberculosis. In Tuberculosis and the Tubercle Bacillus, 2nd edn, pp. 115-140. Edited by S. T. Cole and others. Washington, DC: American Society for Microbiology.